Literature DB >> 14748521

Sexuality at the end of life.

Julie M Stausmire1.   

Abstract

There is very little research literature that addresses sexuality at the end of life. Although end-of-life care has become a priority for nursing education, the issue of end-of-life sexuality is not included in the curriculum. Nurses are frequently in a position to establish relationships with couples that encourage a frank discussion and information sharing. As patient advocates, nurses can address end-of-life sexuality issues by taking a sexual history and implementing a general intervention model, such as the PLISSIT. Couples need to be reassured that if they have enjoyed a close sexual relationship, sexual intimacy may continue to be part of their relationship, even at the end of life.

Entities:  

Mesh:

Year:  2004        PMID: 14748521     DOI: 10.1177/104990910402100109

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  5 in total

Review 1.  Sexual issues in early and late stage cancer: a review.

Authors:  Sebastiano Mercadante; Valentina Vitrano; Viviana Catania
Journal:  Support Care Cancer       Date:  2010-03-18       Impact factor: 3.603

2.  Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer.

Authors:  Kathrin Milbury; Hoda Badr
Journal:  Psychooncology       Date:  2012-05-04       Impact factor: 3.894

Review 3.  Communication About Sexuality in Advanced Illness Aligns With a Palliative Care Approach to Patient-Centered Care.

Authors:  Margaret W Leung; Shari Goldfarb; Don S Dizon
Journal:  Curr Oncol Rep       Date:  2016-02       Impact factor: 5.075

4.  A randomized trial of a minimal intervention for sexual concerns after cancer: a comparison of self-help and professionally delivered modalities.

Authors:  Janette Perz; Jane M Ussher
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

Review 5.  Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer.

Authors:  Mireia Margelí Vila; Sonia Del Barco Berron; Miguel Gil-Gil; Cristian Ochoa-Arnedo; Rafael Villanueva Vázquez
Journal:  Breast       Date:  2020-06-26       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.